Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alekhya Mazumdar
Observed name:
ALEKHYA MAZUMDAR
Institution:
University Hospital Zurich
Observed institutions:
University of Zurich,
ETH Zurich,
University Hospital Zurich,
Universitätsklinik Balgrist,
Institute for Biomechanics
ORCID:
0000-0001-9626-9968
Observed ORCID:
0000-0001-9626-9968
OpenAlex ID:
A5047036088
Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming
2020
·
Alekhya Mazumdar
, Joaquin Urdinez
, et al.
·
International Journal of Molecular Sciences
·
80
PDF
Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model
2020
·
Alekhya Mazumdar
, Joaquin Urdinez
, et al.
·
Cancers
·
44
PDF
The miR-143/145 Cluster, a Novel Diagnostic Biomarker in Chondrosarcoma, Acts as a Tumor Suppressor and Directly Inhibits Fascin-1
2020
·
Joaquin Urdinez
, Aleksandar Boro
, et al.
·
Journal of Bone and Mineral Research
·
43
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
2022
·
Eva Sum
, Moritz Rapp
, et al.
·
Journal for ImmunoTherapy of Cancer
·
30
PDF
The Vault Complex Is Significantly Involved in Therapeutic Responsiveness of Endocrine Tumors and Linked to Autophagy under Chemotherapeutic Conditions
2023
·
Stefan Bornstein
, Igor Shapiro
, et al.
·
Cancers
·
8
PDF
Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer
2026
·
DOMINIK ENDERLIN
, MARIA GLOOR
, et al.
·
Cancer Diagnosis & Prognosis
PDF
Author response for "Combined DNA-PK and PARP inhibition as a therapeutic strategy in BRCA-mutated prostate cancer: an in vitro pilot study"
2025
·
Thomas Paul Scherer
, Souzan Salemi
, et al.
·
Publons reviews and discussion
Combined DNA-PK and PARP Inhibition as a Therapeutic Strategy in BRCA-Mutated Prostate Cancer: An in Vitro Pilot Study
2025
·
Thomas Paul Scherer
, Souzan Salemi
, et al.
·
Technology in Cancer Research & Treatment
Author response for "The miR‐143/145 Cluster, a Novel Diagnostic Biomarker in Chondrosarcoma, Acts as a Tumor Suppressor and Directly Inhibits Fascin‐1"
2020
·
Joaquin Urdinez
, Aleksandar Boro
, et al.
·
Publons reviews and discussion
Author response for "The miR‐143/145 Cluster, a Novel Diagnostic Biomarker in Chondrosarcoma, Acts as a Tumor Suppressor and Directly Inhibits Fascin‐1"
2019
·
Joaquin Urdinez
, Aleksandar Boro
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
10
Citation count:
205
H-index:
5
I10-index:
4
Year
Topic
Type